| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 546,939 | 651,957 | 555,883 | 543,296 | | Cost of Revenue | 276,741 | 351,237 | 291,653 | 286,947 | | | Gross Profit | 270,198 | 300,720 | 264,230 | 256,349 | | | Operating Expenses | | Research Development | 17,249 | 18,643 | 16,218 | 17,419 | | Selling General and Administrative | 176,658 | 183,495 | 168,747 | 167,084 | | Non Recurring | 4,057 | 5,432 | 8,369 | 8,747 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 72,234 | 93,150 | 70,896 | 63,099 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 8,728 |
-
|
-
| | Earnings Before Interest And Taxes | 74,840 | 101,878 | 70,896 | 63,099 | | Interest Expense |
-
| 14,309 | 6,576 | 6,553 | | Income Before Tax | 74,840 | 87,569 | 64,320 | 56,546 | | Income Tax Expense | 7,857 | 18,070 | 20,158 | 17,675 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 66,983 | 69,499 | 44,162 | 38,871 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 66,983 | 69,499 | 44,162 | 38,871 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $66,983 | $69,499 | $44,162 | $38,871 |
|
0.49% Nasdaq 0.00%
Income Statement
